HEADER ANTITUMOR PROTEIN/IMMUNE SYSTEM 30-OCT-24 9E6K TITLE FULLY HUMAN MONOCLONAL ANTIBODY TARGETING THE CYSTEINE-RICH SUBSTRATE- TITLE 2 INTERACTING REGION OF ADAM17 ON CANCER CELLS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN OF MONOCLONAL ANTIBODY C12; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN MONOCLONAL ANTIBODY C12; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN COMPND 11 17; COMPND 12 CHAIN: C; COMPND 13 SYNONYM: ADAM 17,SNAKE VENOM-LIKE PROTEASE,TNF-ALPHA CONVERTASE,TNF- COMPND 14 ALPHA-CONVERTING ENZYME; COMPND 15 EC: 3.4.24.86; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: SPODOPTERA; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 7106; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: SPODOPTERA; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 7106; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ADAM17, CSVP, TACE; SOURCE 16 EXPRESSION_SYSTEM: SPODOPTERA; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7106 KEYWDS INHIBITOR, COMPLEX, ONCOPROTEIN, ANTITUMOR PROTEIN, ANTITUMOR KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR N.SAHA,M.J.DE LA CRUZ,Y.GOLDGUR,D.B.NIKOLOV REVDAT 1 20-NOV-24 9E6K 0 JRNL AUTH N.SAHA,S.G.LEE,E.C.BROCKMANN,M.J.DE LA CRUZ,Y.GOLDGUR, JRNL AUTH 2 R.P.MENDOZA,E.STANCHINA,T.M.LOVE,J.MARVALD,Y.XU,K.XU, JRNL AUTH 3 J.P.HIMANEN,U.LAMMINMAKI,D.VEACH,D.B.NIKOLOV JRNL TITL FULLY HUMAN MONOCLONAL ANTIBODY TARGETING THE CYSTEINE-RICH JRNL TITL 2 SUBSTRATE-INTERACTING REGION OF ADAM17 ON CANCER CELLS. JRNL REF BIOMED PHARMACOTHER V. 180 17605 2024 JRNL REFN ESSN 1950-6007 JRNL PMID 39461016 JRNL DOI 10.1016/J.BIOPHA.2024.117605 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.150 REMARK 3 NUMBER OF PARTICLES : 898088 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9E6K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-24. REMARK 100 THE DEPOSITION ID IS D_1000289527. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF ADAM17 DISINTEGRIN REMARK 245 -CYSTEINE RICH DOMAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6590.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP H 108 14.75 59.72 REMARK 500 ASP H 159 61.90 60.10 REMARK 500 LYS H 229 -174.02 58.42 REMARK 500 ALA L 57 -7.14 71.27 REMARK 500 ALA L 100 -168.75 -162.21 REMARK 500 SER L 191 18.71 59.78 REMARK 500 ASN C 69 -155.88 56.85 REMARK 500 ALA C 70 -108.70 55.55 REMARK 500 PRO C 88 43.39 -84.92 REMARK 500 LEU C 98 -99.43 50.04 REMARK 500 ILE C 109 -35.88 -153.49 REMARK 500 GLU C 125 173.52 -54.98 REMARK 500 THR C 126 70.63 -67.92 REMARK 500 GLU C 148 28.88 44.84 REMARK 500 GLN C 149 64.22 39.87 REMARK 500 ASN C 151 172.87 179.68 REMARK 500 LEU C 152 116.60 -162.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-47571 RELATED DB: EMDB REMARK 900 FULLY HUMAN MONOCLONAL ANTIBODY TARGETING THE CYSTEINE-RICH REMARK 900 SUBSTRATE-INTERACTING REGION OF ADAM17 ON CANCER CELLS. DBREF 9E6K H 1 231 PDB 9E6K 9E6K 1 231 DBREF 9E6K L 1 234 PDB 9E6K 9E6K 1 234 DBREF 9E6K C 60 174 UNP P78536 ADA17_HUMAN 530 644 SEQRES 1 H 216 GLU VAL GLN LEU LEU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 216 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 216 PHE THR PHE SER GLY TYR TRP MET HIS TRP VAL ARG GLN SEQRES 4 H 216 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER ARG ILE THR SEQRES 5 H 216 TYR ASN GLY THR THR ASP TYR ALA ASP SER VAL LYS GLY SEQRES 6 H 216 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 H 216 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 216 VAL TYR TYR CYS ALA ARG GLY TRP LEU ASP VAL TRP GLY SEQRES 9 H 216 GLN GLY THR LEU VAL THR VAL SER SER ALA SER THR LYS SEQRES 10 H 216 GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SER SEQRES 11 H 216 THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS SEQRES 12 H 216 ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER SEQRES 13 H 216 GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL SEQRES 14 H 216 LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL VAL SEQRES 15 H 216 THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR ILE SEQRES 16 H 216 CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP SEQRES 17 H 216 LYS LYS VAL GLU PRO LYS SER CYS SEQRES 1 L 215 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 L 215 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 215 GLN SER VAL SER SER SER ASN LEU ALA TRP TYR GLN GLN SEQRES 4 L 215 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 L 215 SER SER ARG ALA THR GLY VAL PRO ASP ARG PHE SER GLY SEQRES 6 L 215 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 L 215 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 L 215 SER TYR SER LEU PRO TRP THR PHE GLY GLN GLY THR LYS SEQRES 9 L 215 VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 L 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 C 115 ALA GLN LYS LYS CYS GLN GLU ALA ILE ASN ALA THR CYS SEQRES 2 C 115 LYS GLY VAL SER TYR CYS THR GLY ASN SER SER GLU CYS SEQRES 3 C 115 PRO PRO PRO GLY ASN ALA GLU ASP ASP THR VAL CYS LEU SEQRES 4 C 115 ASP LEU GLY LYS CYS LYS ASP GLY LYS CYS ILE PRO PHE SEQRES 5 C 115 CYS GLU ARG GLU GLN GLN LEU GLU SER CYS ALA CYS ASN SEQRES 6 C 115 GLU THR ASP ASN SER CYS LYS VAL CYS CYS ARG ASP LEU SEQRES 7 C 115 SER GLY ARG CYS VAL PRO TYR VAL ASP ALA GLU GLN LYS SEQRES 8 C 115 ASN LEU PHE LEU ARG LYS GLY LYS PRO CYS THR VAL GLY SEQRES 9 C 115 PHE CYS ASP MET ASN GLY LYS CYS GLU LYS ARG HELIX 1 AA1 ARG H 95 THR H 99 5 5 HELIX 2 AA2 ARG H 106 ASP H 116 5 5 HELIX 3 AA3 SER H 171 ALA H 173 5 3 HELIX 4 AA4 PRO H 200 LEU H 204 5 5 HELIX 5 AA5 LYS H 216 ASN H 219 5 4 HELIX 6 AA6 GLU L 95 PHE L 99 5 5 HELIX 7 AA7 SER L 141 GLY L 148 1 8 HELIX 8 AA8 LYS L 203 LYS L 208 1 6 HELIX 9 AA9 PHE C 111 GLN C 116 1 6 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 SER H 18 SER H 26 -1 O SER H 22 N SER H 7 SHEET 3 AA1 4 THR H 86 ASN H 92 -1 O LEU H 89 N LEU H 21 SHEET 4 AA1 4 PHE H 76 ASP H 81 -1 N ASP H 81 O THR H 86 SHEET 1 AA2 6 LEU H 12 VAL H 13 0 SHEET 2 AA2 6 THR H 122 VAL H 126 1 O THR H 125 N VAL H 13 SHEET 3 AA2 6 ALA H 100 ALA H 105 -1 N TYR H 102 O THR H 122 SHEET 4 AA2 6 MET H 39 GLN H 44 -1 N GLN H 44 O VAL H 101 SHEET 5 AA2 6 LEU H 50 ILE H 56 -1 O ILE H 56 N MET H 39 SHEET 6 AA2 6 THR H 65 TYR H 67 -1 O ASP H 66 N ARG H 55 SHEET 1 AA3 4 SER H 135 LEU H 139 0 SHEET 2 AA3 4 ALA H 151 TYR H 160 -1 O LYS H 158 N SER H 135 SHEET 3 AA3 4 TYR H 191 VAL H 199 -1 O VAL H 199 N ALA H 151 SHEET 4 AA3 4 HIS H 179 THR H 180 -1 N HIS H 179 O VAL H 196 SHEET 1 AA4 4 SER H 135 LEU H 139 0 SHEET 2 AA4 4 ALA H 151 TYR H 160 -1 O LYS H 158 N SER H 135 SHEET 3 AA4 4 TYR H 191 VAL H 199 -1 O VAL H 199 N ALA H 151 SHEET 4 AA4 4 VAL H 184 LEU H 185 -1 N VAL H 184 O SER H 192 SHEET 1 AA5 3 THR H 166 TRP H 169 0 SHEET 2 AA5 3 ILE H 210 HIS H 215 -1 O ASN H 212 N SER H 168 SHEET 3 AA5 3 THR H 220 LYS H 225 -1 O LYS H 224 N CYS H 211 SHEET 1 AA6 4 LEU L 4 SER L 7 0 SHEET 2 AA6 4 ALA L 19 ALA L 25 -1 O SER L 22 N SER L 7 SHEET 3 AA6 4 ASP L 86 ILE L 91 -1 O PHE L 87 N CYS L 23 SHEET 4 AA6 4 PHE L 76 SER L 83 -1 N SER L 77 O THR L 90 SHEET 1 AA7 6 THR L 10 SER L 12 0 SHEET 2 AA7 6 THR L 122 GLU L 125 1 O GLU L 125 N LEU L 11 SHEET 3 AA7 6 VAL L 101 GLN L 106 -1 N TYR L 102 O THR L 122 SHEET 4 AA7 6 LEU L 39 GLN L 44 -1 N GLN L 44 O VAL L 101 SHEET 5 AA7 6 ARG L 51 TYR L 55 -1 O ARG L 51 N GLN L 43 SHEET 6 AA7 6 SER L 66 ARG L 67 -1 O SER L 66 N TYR L 55 SHEET 1 AA8 4 THR L 10 SER L 12 0 SHEET 2 AA8 4 THR L 122 GLU L 125 1 O GLU L 125 N LEU L 11 SHEET 3 AA8 4 VAL L 101 GLN L 106 -1 N TYR L 102 O THR L 122 SHEET 4 AA8 4 THR L 117 PHE L 118 -1 O THR L 117 N GLN L 106 SHEET 1 AA9 4 SER L 134 PHE L 138 0 SHEET 2 AA9 4 THR L 149 ASN L 157 -1 O LEU L 155 N PHE L 136 SHEET 3 AA9 4 SER L 194 SER L 202 -1 O SER L 197 N CYS L 154 SHEET 4 AA9 4 SER L 179 VAL L 183 -1 N GLN L 180 O THR L 198 SHEET 1 AB1 4 LEU L 174 GLN L 175 0 SHEET 2 AB1 4 ALA L 164 VAL L 170 -1 N TRP L 168 O GLN L 175 SHEET 3 AB1 4 VAL L 211 HIS L 218 -1 O ALA L 213 N LYS L 169 SHEET 4 AB1 4 VAL L 225 ASN L 230 -1 O PHE L 229 N TYR L 212 SHEET 1 AB2 2 LYS C 63 GLN C 65 0 SHEET 2 AB2 2 SER C 76 TYR C 77 -1 O SER C 76 N CYS C 64 SHEET 1 AB3 3 GLU C 119 CYS C 121 0 SHEET 2 AB3 3 CYS C 133 ARG C 135 -1 O CYS C 133 N CYS C 121 SHEET 3 AB3 3 CYS C 141 VAL C 142 -1 O VAL C 142 N CYS C 134 SSBOND 1 CYS H 23 CYS H 104 1555 1555 2.03 SSBOND 2 CYS H 155 CYS H 211 1555 1555 2.04 SSBOND 3 CYS L 23 CYS L 104 1555 1555 2.04 SSBOND 4 CYS L 154 CYS L 214 1555 1555 2.03 SSBOND 5 CYS C 64 CYS C 85 1555 1555 2.03 SSBOND 6 CYS C 97 CYS C 108 1555 1555 2.03 SSBOND 7 CYS C 121 CYS C 141 1555 1555 2.03 SSBOND 8 CYS C 160 CYS C 171 1555 1555 2.03 CISPEP 1 PHE H 161 PRO H 162 0 -5.74 CISPEP 2 GLU H 163 PRO H 164 0 -4.98 CISPEP 3 SER L 7 PRO L 8 0 -5.79 CISPEP 4 LEU L 114 PRO L 115 0 0.93 CISPEP 5 TYR L 160 PRO L 161 0 5.85 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000